Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL31590476 | 0.93 | — | — | |
| Butane SCHEMBL891634 | 0.93 | — | — | |
| Butane SCHEMBL10767536 | 0.86 | — | — | |
| Butane SCHEMBL2271315 | 0.86 | — | — | |
| Butane SCHEMBL9292387 | 0.84 | TSHR (0.50) | TSHRLMNATHRBSLC22A1ALDH1A1 | |
| Butane SCHEMBL2470336 | 0.84 | TSHR (0.50) | TSHRLMNATHRBSLC22A1ALDH1A1 | |
| Butane SCHEMBL8628663 | 0.84 | TSHR (0.50) | TSHRLMNATHRBSLC22A1ALDH1A1 | |
| Butane SCHEMBL1734106 | 0.84 | — | — | |
| Butane SCHEMBL3593 | 0.84 | — | — | |
| Butane SCHEMBL10583633 | 0.80 | TSHR (0.36) | TSHRLMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6765100-B2 | DISSOLVING N-CARBAMATE-PROTECTED P-AMINOALCOHOL COMPOUND IN SOLVENT TO REMOVE INSOLUBLE MATERIAL; REACTING WITH BASE, THEREBY CONVERTING THE N-CARBAMATE-PROTECTED BETA -AMINOALCOHOL COMPOUND TO AMINOEPOXIDE COMPOUND | AJINOMOTO CO., INC. (JP) | 2004-07-20 | — | — | US | disclosed |
| US-20020072621-A1 | Method for producing epoxide crystal | AJINOMOTO CO., INC. (JP) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020072621-A1 | Method for producing epoxide crystal | EPHX2, CYP2J2, CYP2S1 | TSHR 3051/4885LMNA 2614/4885THRB 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.